Kryptochem Medicament Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 26.18%
- Profit Growth 199.00%
- Ebitda 2812.42%
- Net Worth 72.22%
- Total Assets 48.62%
About Kryptochem Medicament
Kryptochem Medicament Private Limited (KMPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2019 (Six years 10 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Kumar and Varun Singla serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232HR2019PTC078174
-
Company No.
078174
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2019
-
Date of AGM
19 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Kryptochem Medicament?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Kumar
|
Director | 29-Jan-2019 | Current |
|
Varun Singla
|
Director | 29-Jan-2019 | Current |
Financial Performance of Kryptochem Medicament.
Kryptochem Medicament Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.18% increase. The company also saw a substantial improvement in profitability, with a 199% increase in profit. The company's net worth Soared by an impressive increase of 72.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kryptochem Medicament?
Unlock access to Kryptochem Medicament's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Yavinox Lifecare Private LimitedVarun Singla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kryptochem Medicament?
Unlock and access historical data on people associated with Kryptochem Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kryptochem Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kryptochem Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.